J. Hřebačková

Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma.

R. Kizek, E. Frei, M. Stiborová, 2011, Neuro endocrinology letters.

The mechanism of cytotoxicity and DNA adduct formation by the anticancer drug ellipticine in human neuroblastoma cells.

R. Kizek, Václav Martínek, E. Frei, 2009, Biochemical pharmacology.

Mechanisms of ellipticine‐mediated resistance in UKF‐NB‐4 neuroblastoma cells

Z. Zemanová, M. Stiborová, A. Libra, 2012, Cancer science.

Histone deacetylase inhibitors valproate and trichostatin A are toxic to neuroblastoma cells and modulate cytochrome P450 1A1, 1B1 and 3A4 expression in these cells

M. Stiborová, T. Eckschlager, J. Hraběta, 2009, Interdisciplinary toxicology.

The comparison of cytotoxicity of the anticancer drugs doxorubicin and ellipticine to human neuroblastoma cells

M. Stiborová, T. Eckschlager, J. Hraběta, 2008, Interdisciplinary toxicology.

Valproic acid overcomes hypoxia-induced resistance to apoptosis

T. Eckschlager, J. Hraběta, J. Poljaková, 2011, Oncology reports.

Valproic acid in the complex therapy of malignant tumors.

T. Eckschlager, J. Hraběta, J. Hřebačková, 2010, Current drug targets.